|
Drug and Alcohol Dependence 2007;86(1):1-21. [doi: 10.1016/j.drugalcdep.2006.05.012]
Shelly F. Greenfield, MD, MPH (McLean Hospital, NNE Node), Audrey J. Brooks, PhD (University of Arizona, CA/AZ Node), Susan M. Gordon, PhD (Caron Foundation, DV Node), Carla A. Green, PhD, MPH (Kaiser Permanente Northwest, OR/HI Node), Frankie Kropp (CinARC, OV Node), R. Kathryn McHugh, Melissa Lincoln, Denise A. Hien, PhD (Columbia University, LI Node), Gloria M. Miele, PhD (NY State Psychiatric Institute, LI Node).
This paper, a product of the CTN Gender Interest Group, reviews the literature examining characteristics associated with treatment outcome in women with substance use disorders. A search of the English language literature from 1975 to 2005 using Medline and PsycInfo databases found 280 relevant articles. Ninety percent of the studies investigating gender differences in substance abuse treatment outcomes were published since 1990, and of those, over 40% were published since the year 2000. Only 11.8% of these studies were randomized clinical trials. A convergence of evidence suggests that women with substance use disorders are less likely, over the lifetime, to enter treatment compared to their male counterparts. Once in treatment, however, gender is not a significant predictor of treatment retention, completion, or outcome. Gender-specific predictors of outcome do exist, however, and individual characteristics and treatment approaches can differentially affect outcomes by gender. While women-only treatment is not necessarily more effective than mixed-gender treatment, some greater effectiveness has been demonstrated by treatments that address problems more common to substance-abusing women or that are designed for specific subgroups of this population. There is a need to develop and test effective treatments for specific subgroups such as older women with substance use disorders, as well as those with co-occurring substance use and psychiatric disorders such as eating disorders. Future research on effectiveness and cost-effectiveness of gender-specific versus standard treatments, as well as identification of the characteristics of women and men who can benefit from mixed-gender versus single-gender treatments, would advance the field. (Article (Peer-Reviewed), English, 2007)
 Keywords: CTN platform/ancillary study | Gender differences | Literature review | Retention - Treatment | Women | Drug and Alcohol Dependence (journal)
Document No: 96, PMID: 16759822
Submitted by Jack Blaine, MD, CCTN (05/11/2006) |
